Rockwell Medical (RMTI) Gross Margin (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Gross Margin came in at 16.71% in Q1 2026, up 63.0% YoY from 10.25% in Q1 2025, and down 20.94% on a QoQ basis from 21.14% in Q4 2025.
Rockwell Medical (RMTI) Gross Margin (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Gross Margin data on file, last reported at 16.71% in Q1 2026.
- Quarterly Gross Margin rose 63.0% year-over-year to 16.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.07% (down 80.0% YoY) and the FY2025 annual result came in at 16.89%, down 34.0% from the prior year.
- Gross Margin eased to 16.71% in Q1 2026, from 21.14% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 22.03% in Q3 2024 to a low of 4.87% in Q1 2022.
- A 5-year average of 12.56% and a median of 13.51% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin jumped 2667 bps — and 2025, when it plunged 777 bps.
- Tracing RMTI's Gross Margin over 5 years: stood at 12.12% in 2022, then grew by 7 bps to 12.99% in 2023, then advanced by 13 bps to 14.72% in 2024, then jumped by 44 bps to 21.14% in 2025, then slipped by 21 bps to 16.71% in 2026.
- The last three Gross Margin figures came in at 16.71% (Q1 2026), 21.14% (Q4 2025), and 14.27% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 18.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.24% |
| Mar 31, 2026 | 16.71% |
| Dec 31, 2025 | 21.14% |
| Sep 30, 2025 | 14.27% |
| Jun 30, 2025 | 15.57% |
| Mar 31, 2025 | 16.08% |
| Dec 31, 2024 | 14.72% |
| Sep 30, 2024 | 22.03% |
| Jun 30, 2024 | 17.61% |
| Mar 31, 2024 | 13.51% |
| Dec 31, 2023 | 12.99% |
| Sep 30, 2023 | 9.26% |
| Jun 30, 2023 | 5.71% |
| Mar 31, 2023 | 13.21% |
| Dec 31, 2022 | 12.12% |
| Sep 30, 2022 | 4.16% |
| Jun 30, 2022 | 9.34% |
| Mar 31, 2022 | -4.87% |
| Dec 31, 2021 | -14.55% |
| Sep 30, 2021 | -2.06% |